CD44, a transmembrane glycoprotein receptor for extracellular matrix molecules such as hyaluronic acid and osteopontin, is involved in glioma cellular signalling, adhesion and invasion. Although a great deal is known concerning the molecular players in adhesion, migration and invasion, little is known relating to how these invasive and migratorypromoting proteins influence biomechanical properties of glioma cells. Herein, we extend previous CD44 blocking experiments to examine effects of CD44 knock-down on expression of cytoskeletal proteins and cellular stiffness.
Introduction
Glioma cell invasion is strongly influenced by multiple modes of interactions including tumour cell/host cell communication and signalling and biophysical properties of both tumour cell and extracellular matrix (ECM) [1, 2] . The glioma microenvironment is dynamic in nature and, in response to therapies, will adapt to survive. While our understanding of host/tumour, immune/tumour interactions are improving, the appreciation of how biomechanical and biophysical properties contribute to influencing glioma growth and invasion is beginning to be recognised [1, 3] . Identification of key host/tumour interactions and the integration of how mechanical cues drive tumour adaptations could provide potential targets involved in therapeutic resistance. Mechanical cues that can potentially influence the invasive process include substrate stiffness, fluid shear flow and local and global cell strain due to host/tumour changes (i.e., growth, edema). How a glioma cell responds to mechanical cues will most likely depend on its genomic, epigenomic, and proteomic composition as well as ECM stiffness. It will be important to understand the integration of biophysical information during changes associated with glioma growth and during therapeutic challenges in terms of understanding adaptive mechanisms [2] . The ability of a cell to deform is related to cytoskeletal components, actin, microtubulin, and intermediate filaments [4, 5] . The degree to which particular cytoskeletal component is more important may be dependent on experimental systems [5] . There is a documented association of mechanical phenotype with cancer development; however specific mechanisms are yet to be agreed upon [4, 6, 7] . Recent studies on the dynamic reorganisation of the cytoskeleton in cancer cells have drawn great interest in understanding mechanical properties involved in cancer invasion and metastasis [4, [8] [9] [10] . Changes in such biomechanical properties and cytoskeletal reorganisation have been observed in cancer cells of aggressive phenotypes [4, 10] . Indeed, it has been suggested that the elastic properties (i.e., stiffness) of tissue/cells could be an indication of cancer [11, 12] , and previous studies using different biomechanical assays have revealed a correlation between reduced stiffness and increased metastatic potential of human cancer cells [13] .
CD44 is a transmembrane receptor expressed on glioma cells and is known to be involved in cell adhesion, glioma invasion and migration [14] [15] [16] [17] [18] . CD44 serves as a cell receptor for hyaluronic acid [20, 21] and osteopontin [20] . Hyaluronic acid (HA), a glycosaminoglycan [21] , is a major component of brain ECM and high levels, corresponding to increased malignancy, are expressed in tumours [22] [23] [24] . HA binds to the surface of GBM cells via CD44, a cell adhesion glycoprotein [26] , which is essential for the maintenance of the threedimensional structure of organs/tissues; CD44 is present in many cells including normal astrocytes, but is significantly upregulated in GBM [26] . Recently, it has been reported that CD44 expression correlates with short survival in the proneural subtype of GBM [20] . We have previously described that inhibition of CD44 expression in glioma cell lines, either by antibody blocking or gene silencing (siRNA), produced GBM cells that lacked invadopodia, were rounder and less invasive than wild type cells [27] . This effect was mediated in part by RhoGTPase signalling [27] . This signalling pathway has been implicated in cellular stiffness in U373 glioma cells [28] . In the current paper, we report the effects of CD44 knockdown in glioma cell lines with an emphasis on the examination of cytoskeletal protein expression and cellular stiffness measured using atomic force microscopy (AFM). This technology allows determination of the ability of a cell to deform through the analysis of force vs. displacement curves, obtained by placing the AFM probe over the cell and making nanoindentations. This measure of deformity or elasticity is known as the elastic modulus or Young's modulus (E) [29, 30] . While discovered as a means to examine different types of materials, E is classically defined as the ratio of stress (force / area) along an axis to strain (deformation) in which Hooke's law (restoring force to a spring is proportional to a small displacement) holds [31, 32] . AFM nanoindentation studies have been performed on a variety of cell types to obtain E values, which typically range from 100 Pa (epithelial, compliant) [33] to 100 GPa (enamel, stiff) [34] . Such measurements have also been carried out on a broad range of cancer cells and tissues, including bladder [35, 36] , breast [6, [37] [38] [39] [40] , cervical [41] , esophageal [42] , liver [43, 44] , lung [37] , ovarian [4, 45] , pancreas [37, 46, 47] , prostate [6, 48, 49] , thyroid [50] and melanoma [10] . In most studies, AFM measurements were usually performed by probing specific regions of the cell, such as central [37, 38, 48] , above the nucleus [4, 6, 10, 41, 42, 49] , or perinuclear regions [45, 49] . Typically, cancer cells are less stiff (lower E) compared to their benign counterparts. It has been suggested that softer cells are more motile than stiffer cells and this has been linked to the ability of malignant cells to invade and metastasise in vivo [4, 7, 35, 37, 45] . In this paper, we report on the effects of CD44 knock-down in glioma cell lines with an emphasis on the examination of specific cytoskeletal protein expression and cellular stiffness (E) obtained from AFM measurements.
Materials and Methods

Cells
The established human glioblastoma cell line, SNB-19 (passage-44), was obtained from the DSMZ German Brain Tumour Bank (Germany). The cell lines were authenticated using an STR-PCR kit, GenePrint 10 (Promega, UK), as per the manufacturer's instruction. The STR profile of the cells was compared with the DSMZ database to confirm the identity of the SNB-19 cells. Cells are routinely mycoplasma tested utilizing a kit from Lonza, Germany. Cell authentication is also routinely checked using a microfluidic electrophoresis system incorporating an Agilent 2100 Bioanalyzer (Agilent Technologies, USA) to analyse STR-PCR fragments from 10 human genomic loci of human cell lines [51] . CD44 knock-down in SNB-19 cells was achieved by CD44-targeting SMARTpool ® siRNA transfection (Dharmacon, UK), following the manufacturer's instructions [27] . Briefly, SNB-19 cells were incubated with CD44-siRNA for 96 h to achieve > 80% knock-down of the target gene and for 120 h in morphology assays. An Accell TM non-targeting pool siRNA was included in the knock-down experiments as the negative control and GADP-siRNA as the positive control. The GADPsiRNA also served to optimise and monitor efficiency of siRNA delivery into SNB-19 cells [27] . All cells were cultured in Dulbecco's Modified Eagle Medium (Gibco, UK) with 10% foetal calf serum (Sigma, Dorset, UK). Secondary Antibodies. Fluorochrome-conjugated AlexaFluor-488 (Invitrogen) was used in flow cytometry and ICC both at dilution 1:500. Horseradish peroxidase (HRP)-conjugated IgG (Invitrogen) was used for chemiluminescent detection in Western blotting (1:1000).
Antibodies
Immunocytochemistry (ICC)
ICC was carried out following an established procedure previously described [27] . Cells were fixed with 4% paraformaldehyde (PFA) (Sigma, UK) and permeabilised with 0.2% Triton X-100 (Sigma, UK) for intracellular antigen detection before incubation with the primary antibody. Cells were then incubated with the relevant secondary antibody. Cells were washed with 1×PBS before and after each antibody's incubation. Nuclei were counterstained with Hoechst Blue (Sigma, UK) and the slides were viewed using a Zeiss Axio Imager Z1 fluorescence microscope (Carl Zeiss, Welwyn Garden City, UK). Images were captured using Volocity Image Analysis Software (V5.2, Perkin Elmer, Cambridge, UK).
Flow cytometry
Flow cytometry was performed based on standard protocols [27] . Briefly, cells were permeabilised with cytofix/cytoperm solution (BD Biosciences, UK) for intracellular antigen staining prior to primary antibody incubation. Cells were then washed with 5% serum/PBS and incubated with the corresponding secondary antibody. After the incubation, cells were washed and resuspended in 1% serum/PBS then transferred to fluorescence-activated cell sorting (FACS) tubes (BD Biosciences) for analysis. Each sample was analysed in triplicate plus one negative control where primary antibody was omitted, and the experiment was repeated three times. Analysis was performed on a four-colour-multi-parameter FACS Calibur (BD Biosciences) and the expression level was assessed by the percentage of positive cell population [positive cells (%)], as described previously [28] .
Western blotting (WB)
Cell lysates were separated in the "any kDa" pre-cast SDS-PAGE gel (Bio-rad Laboratories Ltd, UK) and transblotted onto a polyvinylidene difluoride membrane (GE Healthcare Life Sciences, UK). Immunodetection was achieved using the primary antibodies and horseradish peroxidase-conjugated secondary antibodies. The blot was then visualised and analysed with the GBOX Chemi XT16 system (Synoptics). Parental SNB-19 cells and nontargeting siRNA treated cells were used as controls in various assays (refer to individual results and figure legends). For siRNA knock-down experiments, all transfected cells were harvested after 96 h siRNA-incubation for lysate extraction.
Migration assay
Cell migration was assessed through the Transwell TM modified Boyden Chamber assay. Cells were grown in serum free media. The Transwell TM inserts used were 8 µm porosity, polycarbonate membrane filters within 24-well plates (Corning, UK). Platelet-derived growth factor (PDGF AB ; 10 ng/ml; Universal Biologicals Cambridge, UK) diluted in serum free media (SFM) was used as a chemoattractant and added to the lower chamber of the well. Cells were harvested, counted and seeded at a concentration of 110 5 cells/100 µl SFM in the upper compartment of the Transwell TM unit. Migration was allowed to occur for 6 h at 37 ºC in a 5% CO 2 chamber. The filters were then removed and fixed in methanol. Non-migrated cells on the upper surface of the filter were removed with a cotton swab and migrated cells, adherent on the lower filter surface were stained with Diff Quick (BDH Laboratory Supplies, UK) and cells were counted in 5 random fields. Each experiment was performed in triplicate. Mean values of migrated cells for each point were calculated. Migration was expressed as mean ± SEM of the number of total cells counted per well.
Confocal microscopy
Confocal microscopy was carried out with a Zeiss LSM 510 Meta Axioskop2 confocal microscope (Carl Zeiss), as previously described [27] . Fluorescence was detected using excitation wavelengths of 488 nm (green), 568 nm (red) and 405 nm (blue), with an argon, HeNe1 and diode laser, respectively. Multi-track image capture was performed with two channels so that different colours were imaged by separate channels to prevent any overlap in excitation spectra. Identical settings were used to capture images of negative controls where primary antibody was omitted.
AFM elasticity measurements
AFM nanoindentation experiments were carried out using a CellHesion 200 AFM (JPK Instruments, Cambridge, UK) mounted on a Zeiss Axiovert 200M (Carl Zeiss) inverted optical microscope placed on a Halcyonics Micro 40 anti-vibration table (Accurion, Goettingen, Germany). A Petri dish of cells (in growth media, lid removed; glass-bottomed) was placed on an integrated Petri dish heater (37 °C; JPK Instruments) and a 20 objective, on the inverted microscope, was used to locate cells of interest. In this experimental design, only single, isolated cells were investigated to avoid influence from neighbouring cells [48] . An 'arrow-shaped', tipless cantilever (Arrow-TL1-50; nominal length l nom = 500 µm, k nom = 0.03 N m -1 ; NanoWorld, Neuchatel, Switzerland) with a pre-attached glass microsphere (radius of curvature R = 5.6 µm) was used in all experiments; the use of a single probe was considered to reduce errors (ca. 15 -20%) introduced by cantilever spring constant (k) measurement [52] . This property was determined prior to bio-indentation studies using the method of Hutter and Bechhoefer (k = 0.02876 N m -1 ) [53] and obtaining a force vs. distance curve on the bottom of the glass Petri dish (in media) in a region devoid of cells. The AFM probe was lowered into the medium, positioned above the region of interest and an optical microscopy image was obtained for each cell. The probe was then brought into contact with the surface using the automated approach. Force vs. distance curves were obtained on nuclear and cytoplasmic (off-nuclei) regions (50 cells of each cell type, one force curve per region of the cell; N = 50  2). For the latter regions, the AFM probe did not 'reach over' the nuclei and therefore possible undesirable cantilever-nuclei interactions were avoided. An approach distance of 50 µm, a force set-point of 10 nN (before releasing the applied load) and a tip velocity of 5 µm s -1 were used. Indentation speeds between 3 and 16 µm s -1 have been shown to result in relatively constant E values [54] . Force curve acquisition and data processing was performed using the AFM software (JPK Data Processing Software V5.1.13). Force curves (approach cycle) were off-set (baseline) and tilt corrected; the contact point (CP) in each curve was estimated by visual inspection (deviation from baseline) and heights corrected for cantilever bending (converted to tip-sample separation). E values were then obtained by fitting the corrected approach force curves to a Hertzian model, which describes the variation of applied load F with indentation  as a sphere (radius R; at the end of a parabolic indenter) is pressed into an elastic half-space [55] :
where  = Poisson ratio (0.5, assuming cells to be flat, isotropic and incompressible, in keeping with most studies on soft biological systems [56] .
BioNanoScience
Indentations initially were restricted to ca. 10% of the cell thickness (nuclear regions), since above this range, substrate effects make a large contribution to the apparent stiffness and the Hertz model may no longer be applied [54] [55] [56] [57] . Thus, cell thickness measurements of wild type SNB-19 cells (same media and glass-bottomed petri dish) were obtained from AFM line-profiles (NanoWizard 3, JPK Instruments) using an 'arrow-shaped' Si cantilever (HQ:CSC37/No Al; probe 'C', nominal length l nom = 300 ± 5 µm, width w nom = 35 ± 3 µm, thickness t nom = 2.0 ± 0.5 µm, spring constant k nom = 0.4 N m -1 ; Mikromasch Europe, Wetzlar, Germany) with integrated tip (R = 8 nm, h = 12 -18 µm; n = 10). Cell thicknesses were 8.2 ± 3.3 and 1.1 ± 0.4 µm for nuclear and cytoplasm, respectively;  values were restricted to ca. 0.5 µm from the CP, which provided a good Hertzian model fit of the force-distance AFM data in the case of nuclear regions. The indentation of ca. 50% of cell thickness for cytoplasmic areas yielded more stable Hertzian fit plots, although the resultant E values agreed with those obtained at 10% indentation in most cases. Some force-curves (< 5%), from all cell types, were rejected during acquisition due to nonfavourable tip-sample interactions (erroneously shaped curves). Differences in E values associated with using the spherical indenter model rather than the chosen parabolic indenter model, which is sufficient for shallow contacts, were < 10%, and within the error of accurately determining k.
Since CD44 siRNA knock-down was only partially complete, a proportion of the cells deemed to be knocked down were selected for further analysis. This was carried out by 3 of the investigators (ZM, QA and HF) independently examining the phase contrast images of each cell taken immediately before AFM data acquisition. This was done in a masked fashion with images not identifiable until after examination. Cells were only deemed knocked down when there was a 100% consensus of images where the morphology was similar to published reports [27] .
Statistics
Migration and Flow analysis: Statistical analysis was performed using one-way ANOVA followed by Tukey's multiple comparison post-test with a probability  of less than 0.05 being regarded as significant. The software package GraphPad Prism 3.02 was used to calculate the statistical tests where all data are expressed as mean values.
AFM analysis: E values (independent groups; nuclear and cytoplasm areas) were analysed using Q-Q plots and normality tests (Shapiro-Wilks;  = 0.05, two-tailed) were used to compare distributions [58] . Homogeneity was tested using a Levene's test ( = 0.05, twotailed) and Student's t-tests ( = 0.05, two-tailed) used to compare means [58] . All statistics were performed using SPSS Statistics 21 (IBM SPSS, NY, USA).
Results
Previously, we have shown that blocking CD44 expression in glioma cells resulted in a repression of cell invasion and this effect was mediated in part by RhoGTPase signalling [27] . In this report, we have extended these studies and examined the downstream effects of CD44 knock-down on the expression of cytoskeletal proteins involved in cellular migration and cellular stiffness (E). SNB-19 glioma cells transfected with CD44 siRNA contained lower CD44 protein levels compared with those transfected with scrambled control siRNA (Fig.  1a) . Functionally, SNB-19 cells transfected with CD44-targeted siRNA were less migratory than parental SNB-19 cells (Fig. 1b, p < In agreement with our previous study [27] , knock-down of CD44 in SNB-19 cells resulted in a dramatic change in cellular morphology (Fig. 2a) . In CD44 knock-down cells, the cells tended to appear rounder, lose the distinct CD44 positive staining and contain fewer processes. F-actin, vimentin, GFAP and microtubule positive staining was less pronounced in CD44 knock-down SNB-19 cells compared to control SNB-19 cells. While vimentin positive staining was associated with prominent filamentous staining in control cells, vimentin staining in CD44 knock-down cells appeared to be more granular and punctuated at focal adhesion points near edges of cells (Fig. 2, arrows) . GFAP staining in CD44 knock-down cells seem to lose most of the central cytoplasmic positive staining. 2015, pp. 1-11, doi: 10.1007/s12668-015-0189-2  www.link.springer.com/article/10.1007/s/12668-015-0189-2 9 2015, pp. 1-11, doi: 10.1007/s12668-015-0189-2  www.link.springer.com/article/10.1007/s/12668-015-0189-2 Quantitative analysis using flow cytometric analysis demonstrated that the reduction in Factin, vimentin, GFAP and microtubule expression in SNB-19 CD44 knock-down cells was significant compared with wild type SNB-19 cells (Fig. 2c-d, p < 0.05) . Similar results demonstrating the reduction in vimentin, GFAP and microtubule expression in CD44 knockdown cells were seen in Western Blot analysis (Fig. 2e) .
We next asked the question if the changes in morphology and reduced cytoskeletal protein expression and migration seen in CD44 knock-down SNB-19 cells was associated with a difference in mechanical properties, specifically, cell stiffness (E). Prior to the analysis of cell stiffness, we needed to insure that the AFM measurements were conducted on cells with CD44 knocked down, as siRNA silencing of CD44 in SNB-19 cells did not result in a total reduction of CD44 protein (Fig. 1a) . Images were taken of every cell in which E values were determined (Fig. 3a) . For identifying CD44 knock-down cells, three investigators independently scored all images in a blinded fashion and where there was 100% agreement on morphological changes associated with CD44 knock-down, these values were analysed. E values of wild type SNB-19 and SNB-19/CD44 knock-down cells, from nuclear and cytoplasmic regions, were extracted from AFM force-distance curves (Fig. 3b) . This property was found to be log-normally distributed, as observed elsewhere for other types of cancer cells [37] ; AFM nanoindentation results show the area over the nucleus of cell lines examined were significantly more compliant (pliable) than their cytoplasmic regions (Fig.  3c , p < 0.001). The most striking difference was seen when comparing nuclear regions of parental cells to those of CD44 knock-down cells. CD44 knock-down SNB-19 cells (E = 0.56 ± 0.50 kPa) were less stiff than wild type cells (E = 1.93 ± 2.86 kPa; p < 0.001).
Discussion
In this report, we have extended our studies exploring potential mechanisms involved in CD44-mediated glioma cell invasion by investigating changes in cytoskeletal proteins and biomechanical properties associated with inhibition of CD44 expression. Cell invasion involves the coordinated integration of many signals and while much is known concerning the role of specific genes and proteins and their associated signalling pathways, little is known on the influence of biophysical processes that may contribute to glioma invasion. These are important to consider as increased cell invasion is likely to include the ability of the cell to resist deformation and increase the rate of cytoskeletal dynamics [4, 5] . This is not a novel concept as Herpers et al., in the mid-1980s, suggested that glioma cells are able to adapt to the microenvironment via changes in the cytoskeleton [59] . In this paper, we demonstrate that by knocking down CD44 expression in a glioma cell line (SNB-19) there is an associated decreased expression of the intermediate filament proteins, vimentin and GFAP and of microtubules. Cell migration was decreased in CD44 knock-down cells in agreement with published reports that show that inhibition of CD44 expression in glioma cells result in a decrease in glioma invasion [27] . We hypothesised that by knocking down CD44 and there would be an associated change in glioma cell deformity; specifically, that the CD44 knock-down cells would become less pliable (more stiff and increased E values). Much of the published information concerning this area assumes that, in general, E values of invasive cancer cells are lower (more pliable) than their normal cell counterparts [13] . In other words, the effect on reduced migration could be due, in part, to a change in mechanical stiffness and that by increasing cellular stiffness, invasion would be decreased. However, our results showed that CD44 knock-down glioma cells were less stiff than control cells. This difference was only seen in the area over the nucleus as there was no difference in cellular stiffness when AFM nanoindentation measurements were conducted away from the nucleus. Recently, Rathje et al. [60] reported that cellular stiffness was associated with the reorganisation of vimentin. Interestingly, vimentin is known to be perinuclear and its network extends throughout the cell during migration [61] . Rathje et al. showed that oncogenes can induce vimentin filament collapse and this is mediated by Histone deacetylase 6 (HDAC6), an enzyme responsible for deacetylation of histones resulting in condensed chromatin [60] . In our current work, one of the most apparent changes among the cytoskeletal proteins examined was seen in vimentin expression and its cellular distribution. We have previously shown that the functional effects of inhibiting CD44 are mediated, in part, by RhoGTPase signalling [27] . Transfection of U373 glioma cells with a constitutively active RhoGTPase resulted in an increase cellular stiffness, as measured by AFM nanoindentation [28] . We propose that in our experimental design, knockdown of CD44 leads to a decrease in vimentin and that the decrease in stiffness around the nucleus is in part due to the re-organisation of vimentin (Fig. 4) . There is evidence that supports the idea that the nucleus can serve as a mechanosensor of external and internal forces [62, 63] and the tethering of chromatin to the nuclear envelope can affect nuclear stiffness [64] . Lamin proteins are key players that help connect chromatin and the cytoskeleton [65] [66] [67] , and levels of lamin protein expression have been shown to influence cell migration and cell viability [67] . The role of the lamin proteins in mechanotransduction and nuclear function is a very exciting area of research and information from these investigations will provide much needed knowledge into the regulation of gene expression due to biomechanical and microenviornmental stresses in GBM. As evidence increases as to the importance of a dynamic tumour microenvironment, the incorporation of mechanical properties and how tumour and host cells respond to external forces will be critical for a better understanding of host/tumour interactions. The cytoskeletal proteins allow the cell to adapt to microenvironmental changes. While cell deformation characteristics are determined by cytoskeletal dynamics [5] , consideration of the factors that influence nanomechanical properties should be considered when making comparisons of observed E values between studies. The cellular thickness, depth and [6] . While there are many studies on different types of cancers that report that cancer cells are less stiff than less aggressive or non-neoplastic control cells, currently the strongest comparison that holds that cancer cells are less stiff than cells of same origin are in ovarian and bladder cancers [71] . Although our data demonstrate a decrease in glioma cell stiffness in less invasive cells, comparing the same isogenic cell line except for knocking down CD44, the general statement 'more aggressive, invasive cells are less stiff' probably does not hold true for all cancer cell types and is likely to be dependent on context and will vary depending on microenvironmental stresses. These issues should be considered for future studies on investigating the influence of biomechanical properties on glioma host/tumour interactions and glioma cell invasion.
